France· FR:69729088
EVRA 203 microgrammes/24 heures + 33,9 microgrammes/24 heures, dispositif transdermique
A medicinal product containing éthinylestradiol + norelgestromine, registered in France by GEDEON RICHTER ( HONGRIE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉTHINYLESTRADIOL + NORELGESTROMINE
- Manufacturer
- GEDEON RICHTER ( HONGRIE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009360514613 sachet(s) polyéthylène basse densité (PEBD) aluminium papier de 1 dispositif(s)
- cip1334009360515229 sachet(s) polyéthylène basse densité (PEBD) aluminium papier de 1 dispositif(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Éthinylestradiol + norelgestromine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainEVRA 203 MICROGRAMOS/24 hORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICOJanssen-Cilag International N.V
- United StatesGwyn LoViatris Specialty LLC
- CzechiaEVRAGedeon Richter Plc., Budapešť
- United KingdomEvra transdermal patchesDowelhurst Ltd
- IrelandEvraGedeon Richter Plc
- SwitzerlandEvra, transdermales PatchGedeon Richter (Schweiz) AG
- FinlandEvraGedeon Richter Plc
- IcelandEvraGedeon Richter Plc.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Evra
- Liechtenstein · Evra
- Norway · Evra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/12814219-4526-4659-9097-4d2ccc602ea2 GET /v1/drugs/12814219-4526-4659-9097-4d2ccc602ea2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69729088",
"date_amm": "2002-08-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/02/223",
"substance": "ÉTHINYLESTRADIOL + NORELGESTROMINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "dispositif",
"voies_administration": "transdermique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about éthinylestradiol + norelgestromine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.